Clase Neera
Reporting owner on Forms 3, 4 and 5, CIK 2162845.
Clase Neera reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. CIK 1819790 | officer (Chief Commercial Officer) | 2 | 2026-11-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative | 2026-11-03 | A granted | +10,587 | $0 | 10,587 | Form 4 |
| TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative | 2026-11-03 | A granted | +6,678 | $0 | 6,678 | Form 4 |
| TARS · Tarsus Pharmaceuticals, Inc.Common Stock, holding | 14,800 | Form 3 | ||||
| TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Stock Option (right to buy), derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding | Form 3 | |||||
| TARS · Tarsus Pharmaceuticals, Inc.Restricted Stock Units, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002162845-26-000005 | Tarsus Pharmaceuticals, Inc. | 2026-11-05 | ||
| Form 3 0002162845-26-000004 | Tarsus Pharmaceuticals, Inc. | 2026-11-05 |